Alterity Therapeutics (ATHE) Revenue (2016 - 2019)

Alterity Therapeutics' Revenue history runs 4 years deep, the most recent figure standing at $1.2 million for Q4 2019.

• On a quarterly basis, Revenue fell 27.83% year-over-year to $1.2 million in Q4 2019; TTM through Dec 2019 was $4.2 million, a 32.02% increase from a year earlier, with the FY2024 full-year figure at $47357.5, changed N/A from the prior year.
• Revenue fell to $1.2 million in Q4 2019 per ATHE's latest filing, from $1.7 million in the prior quarter.
• Across five years, Revenue topped out at $1.7 million in Q4 2018 and bottomed at -$87534.3 in Q4 2017.
• The 4-year median for Revenue is $1.3 million (2016), against an average of $1.0 million.
• Across the five-year window, Revenue slumped 106.67% in 2017 and surged 2065.6% in 2018, its largest moves.
• Year by year, Revenue stood at $1.3 million in 2016, then sank by 106.67% to -$87534.3 in 2017, then surged by 2065.6% to $1.7 million in 2018, then slipped by 27.83% to $1.2 million in 2019.
• Per Business Quant, the three latest ATHE Revenue figures stand at $1.2 million (Q4 2019), $1.7 million (Q4 2018), and -$87534.3 (Q4 2017).